AU2002354476A1 - Pyrazolopyridine derivatives and medicinal use thereof - Google Patents

Pyrazolopyridine derivatives and medicinal use thereof

Info

Publication number
AU2002354476A1
AU2002354476A1 AU2002354476A AU2002354476A AU2002354476A1 AU 2002354476 A1 AU2002354476 A1 AU 2002354476A1 AU 2002354476 A AU2002354476 A AU 2002354476A AU 2002354476 A AU2002354476 A AU 2002354476A AU 2002354476 A1 AU2002354476 A1 AU 2002354476A1
Authority
AU
Australia
Prior art keywords
medicinal use
pyrazolopyridine derivatives
pyrazolopyridine
derivatives
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002354476A
Inventor
Kazuyuki Hirata
Koichi Ozawa
Kazuhiko Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of AU2002354476A1 publication Critical patent/AU2002354476A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2002354476A 2001-12-14 2002-12-13 Pyrazolopyridine derivatives and medicinal use thereof Abandoned AU2002354476A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001382398 2001-12-14
JP2001-382398 2001-12-14
JP2002225343 2002-08-01
JP2002-225343 2002-08-01
PCT/JP2002/013059 WO2003051876A1 (en) 2001-12-14 2002-12-13 Pyrazolopyridine derivatives and medicinal use thereof

Publications (1)

Publication Number Publication Date
AU2002354476A1 true AU2002354476A1 (en) 2003-06-30

Family

ID=26625083

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002354476A Abandoned AU2002354476A1 (en) 2001-12-14 2002-12-13 Pyrazolopyridine derivatives and medicinal use thereof

Country Status (3)

Country Link
JP (1) JPWO2003051876A1 (en)
AU (1) AU2002354476A1 (en)
WO (1) WO2003051876A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765783B2 (en) 2002-06-26 2014-07-01 Ono Pharmaceuticals Co., Ltd. Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation
CA2498944C (en) 2002-09-19 2011-05-17 Yasushi Kohno Amino alcohol derivatives, salts thereof and immunosuppressive agents
AU2003289024A1 (en) * 2002-12-12 2004-06-30 Takeda Pharmaceutical Company Limited Novel use of edg receptors
EP2172472B1 (en) 2003-02-18 2012-12-26 Kyorin Pharmaceutical Co., Ltd. Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor
CN102964294A (en) 2004-09-02 2013-03-13 遗传技术研究公司 Pyridyl inhibitors of hedgehog signalling
WO2007087429A2 (en) * 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Phenyl and pyridyl compounds for inflammation and immune-related uses
JP4948913B2 (en) * 2006-06-16 2012-06-06 上野製薬株式会社 Method for producing naphthalenecarboxylic acid amide
RU2430925C2 (en) 2006-08-08 2011-10-10 Киорин Фармасьютикал Ко., Лтд. Aminophosphate derivative and s1p receptor modulator containing said derivative as active ingredient
US8273748B2 (en) 2006-08-08 2012-09-25 Kyorin Pharmaceutical Co., Ltd. Amino alcohol derivative and immunosuppresive agent having same as an active ingredient
AU2009305565A1 (en) 2008-10-17 2010-04-22 Exelixis, Inc. Synergistic combination of sphingosine-1-phosphate receptor antagonists and antimicrotubule agents
JP2013506003A (en) * 2009-09-29 2013-02-21 アラーガン インコーポレイテッド Fused ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors
JPWO2011087051A1 (en) * 2010-01-14 2013-05-20 国立大学法人金沢大学 Atherosclerosis therapeutic agent comprising S1P2 receptor antagonist
CN104334556B (en) * 2012-03-26 2017-05-17 爱若优生物科技有限公司 Novel sphingosine 1-phosphate receptor antagonists
WO2015184541A1 (en) 2014-06-02 2015-12-10 Dalhousie University Treatment of familial exudative vitreoretinopathy through s1pr2 inhibition
US10487082B2 (en) 2015-06-01 2019-11-26 Dalhousie University S1PR2 antagonists and uses therefor
CA2987796A1 (en) * 2015-06-01 2016-12-08 Dalhousie University S1pr2 antagonists and uses therefor
US10858358B2 (en) 2015-06-01 2020-12-08 Dalhousie University S1PR2 antagonists and uses therefor
US10464897B2 (en) * 2015-06-05 2019-11-05 Dana-Farber Cancer Institute, Inc. Compounds and methods for treating cancer
BR112019001732A2 (en) * 2016-07-29 2019-05-07 Flx Bio, Inc. chemokine receptor modulators and uses thereof
CN111918652A (en) 2017-11-06 2020-11-10 拉普特医疗公司 Chemokine receptor modulators for the treatment of epstein-barr virus positive cancers
CN110950807B (en) * 2018-09-26 2023-03-03 中国科学院上海药物研究所 Biaryl compound, preparation method thereof, pharmaceutical composition and application thereof
WO2023283921A1 (en) * 2021-07-16 2023-01-19 北京深蓝泰医药科技有限公司 Dpd inhibitor, and pharmaceutical composition and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020027463A (en) * 1999-07-12 2002-04-13 우에노 도시오 Fibrosis inhibitors containing as the active ingredient sphingosine-1-phosphate receptor agonist or sphingosine-1-phosphate
GB9929685D0 (en) * 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
WO2003051876A1 (en) 2003-06-26
JPWO2003051876A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
EP1367060A4 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
EP1364957A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
EP1364958A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU1164601A (en) Therapeutic use and formulation
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
PL362571A1 (en) Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
AU2002343103A1 (en) Aminoalkylimidazole derivatives and their use in medicine
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AUPQ462299A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR916301A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR606401A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001228784A1 (en) Inositol derivatives and their pharmaceutical use
AU2002347633A1 (en) Pyrazolopyridine derivtives and their pharmaceutical use
AU2002234871A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
AU2002237536A1 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase